[시장보고서]세계의 중의학(TCM) 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

세계의 중의학(TCM) 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Traditional Chinese Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1660930

리서치사 : Persistence Market Research

발행일 : 2025년 02월

페이지 정보 : 영문 193 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,373,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,768,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,539,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 중의학(TCM) 시장 규모는 2025년에 333억 달러에 달하며, 2025년-2032년의 예측 기간 동안 5.3%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 2032년에는 478억 달러에 달할 것으로 예측되고 있습니다.

중의학(TCM)은 한약, 침술, 캡핑 요법, 태극권 등 다양한 치료법을 포함하여 수세기 동안 다양한 건강 상태를 치료하는 데 사용되었습니다. 이 시장은 천연 허브, 식물성 추출물 및 전통적인 치료 기술에서 유래한 제형을 포함합니다. TCM은 병원, 진료소, 웰니스 센터, 재택치료의 현장에서 널리 채용되고 있어 통증 관리, 만성 질환 치료, 소화기 질환, 면역 시스템 강화 등에 응용되고 있습니다. 시장의 성장은 자연적이고 홀리스틱한 치료법에 대한 소비자의 선호도 증가, TCM의 주류 건강 관리 통합, 현대 의학적 증상에 대한 효능에 대한 연구의 확대에 기여합니다.

세계의 중의학 시장은 대체 및 보완 의료의 인기 증가, 허브와 자연 요법에 대한 소비자의 의식 증가, 통합 의료 환경에서 TCM의 수용 확대 등 몇 가지 중요한 요인에 의해 추진되고 있습니다. 중국, 일본, 한국 등 각국 정부는 정책 지원과 연구 자금 지원을 통해 TCM을 적극적으로 추진하고 시장 확대를 촉진하고 있습니다. 또한, 나노기술을 이용한 허브 추출 및 디지털 TCM 진단 툴 등 TCM 처방에 있어서의 기술의 진보는 치료 효과와 이용 용이성을 높이고 있습니다. 당뇨병, 고혈압, 만성 통증 등의 생활 습관병이 증가하고 있는 것도, TCM에 근거한 치료에 대한 수요를 촉진하고 있습니다.

중의학(TCM) 시장은 R&D 투자 증가, 맞춤형 의료 진보, 웰니스 투어리즘 동향 증가로 큰 성장 기회를 제공합니다. TCM과 AI를 활용한 진단 및 원격 의료 상담과 같은 최신 디지털 헬스 기술과의 통합은 접근성과 환자의 관여를 높이고 있습니다. 게다가 천연 유기치료에 대한 수요가 높아지고 있는 북미와 유럽에서의 수출 기회의 확대가 시장 진출기업에 새로운 길을 열고 있습니다. TCM 제조업체, 제약 회사 및 연구 기관의 전략적 제휴는 기술 혁신과 세계 시장에의 침투를 더욱 촉진할 수 있습니다.

이 보고서는 세계 중의학(TCM) 시장을 조사했으며, 제품별, 질병별, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

경쟁 대시보드
브랜딩 및 프로모션 전략
주요 개발 분석
경쟁의 상세
- Tongrentang
- Zhongxin Pharmaceuticals
- Tianjin Tasly Group
- Yuannan Baiyao
- Solstice Medicine Company, Inc.
- Shanghai Sundise Traditional Chinese Medicine Co., Ltd
- China Chinese Medicine Holding Co., Ltd.
- Hunan goldliloo pharmaceutical Co., Ltd
- Wanbang Pharma Group Corp.
- Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- GlaxoSmithKline PLC
- Mallinckrodt Pharmaceuticals
- Hisamitsu Pharmaceutical Co., Inc.

제20장 사용된 전제조건과 약어

제21장 조사 방법

SHW

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for Traditional Chinese Medicine (TCM). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Traditional Chinese Medicine market from 2025 to 2032.

Key Insights:

Traditional Chinese Medicine Market Size (2025E): USD 33.3 Billion
Projected Market Value (2032F): USD 47.8 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 5.3%

Traditional Chinese Medicine Market - Report Scope:

Traditional Chinese Medicine (TCM) encompasses a range of therapies, including herbal medicine, acupuncture, cupping therapy, and Tai Chi, used for centuries to treat various health conditions. The market includes formulations derived from natural herbs, plant-based extracts, and traditional healing techniques. TCM is widely adopted in hospitals, clinics, wellness centers, and homecare settings, with applications in pain management, chronic disease treatment, digestive disorders, and immune system enhancement. The market's growth is fueled by increasing consumer preference for natural and holistic treatments, the integration of TCM into mainstream healthcare, and expanding research into its efficacy for modern medical conditions.

Market Growth Drivers:

The global Traditional Chinese Medicine market is propelled by several key factors, including the rising popularity of alternative and complementary medicine, increased consumer awareness of herbal and natural treatments, and growing acceptance of TCM in integrative healthcare settings. Governments in countries like China, Japan, and South Korea actively promote TCM through policy support and research funding, fostering market expansion. Additionally, technological advancements in TCM formulation, such as nanotechnology-based herbal extractions and digital TCM diagnostic tools, enhance treatment effectiveness and accessibility. The increasing prevalence of lifestyle-related diseases, such as diabetes, hypertension, and chronic pain, further drives demand for TCM-based therapies.

Market Restraints:

Despite promising growth prospects, the Traditional Chinese Medicine market faces challenges related to regulatory compliance, standardization, and skepticism from the scientific community. The lack of universal standards in herbal medicine formulations and variations in TCM practices across regions create barriers to market expansion. Additionally, concerns over the quality and authenticity of herbal ingredients, along with potential side effects and drug interactions, pose challenges for consumer adoption. Limited clinical research validating the effectiveness of TCM treatments in comparison to conventional medicine also hinders broader acceptance. Addressing these challenges requires rigorous research, standardized quality control, and stronger regulatory frameworks to ensure the safety and efficacy of TCM products.

Market Opportunities:

The Traditional Chinese Medicine market presents significant growth opportunities driven by increasing investment in research and development, advancements in personalized medicine, and the rising trend of wellness tourism. The integration of TCM with modern digital health technologies, such as AI-driven diagnostics and telemedicine consultations, enhances accessibility and patient engagement. Furthermore, expanding export opportunities in North America and Europe, where demand for natural and organic treatments is rising, creates new avenues for market players. Strategic collaborations between TCM manufacturers, pharmaceutical companies, and research institutions can further drive innovation and global market penetration.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the Traditional Chinese Medicine market globally?
Which TCM therapies and applications are gaining the most traction in different healthcare settings?
How are technological advancements shaping the future of the TCM market?
Who are the key players influencing the TCM market, and what strategies are they adopting for market expansion?
What are the emerging trends and growth opportunities in the global Traditional Chinese Medicine market?

Competitive Intelligence and Business Strategy:

Leading players in the global Traditional Chinese Medicine market, including Tong Ren Tang, Yunnan Baiyao, and Beijing Tongrentang Co., Ltd., focus on product innovation, quality standardization, and international market expansion. These companies invest in advanced herbal extraction technologies, conduct clinical research on TCM efficacy, and engage in strategic partnerships with pharmaceutical firms to enhance credibility. Collaborations with hospitals, wellness centers, and e-commerce platforms also facilitate wider market penetration. Additionally, initiatives promoting sustainable and organic sourcing of medicinal herbs ensure long-term market sustainability and consumer trust.

Key Companies Profiled:

Tong Ren Tang
Yunnan Baiyao
Beijing Tongrentang Co., Ltd.
Tasly Pharmaceutical Group Co., Ltd.
China Shineway Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical Holdings
Zhejiang Chinese Medical University Pharmaceutical
Jiangzhong Pharmaceutical Co., Ltd.

Key Segments Covered in Traditional Chinese Medicine Industry Research

Product:

Traditional Chinese Medicine (TCM)
Non-Traditional Chinese Medicine (Non-TCM)

Disease:

Autism Spectrum Disorder (ASD)
Attention Deficit Hyperactivity Disorder (ADHD)

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Recent Product Approval and Launches
4.4. PESTLE Analysis
4.5. Porter's Analysis
4.6. Regulatory Scenario

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Herbal Medicine Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing Adoption Of TCM
- 5.2.2. Massive Infrastructure Planning for Global Manufacturing
- 5.2.3. Favourable Regulatory and Reimbursement Scenario
- 5.2.4. Increasing Research and Development
- 5.2.5. Growth of Top Companies
- 5.2.6. Mergers and Acquisitions
- 5.2.7. Increasing Incidence of Lifestyle Diseases
5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Disease
- 6.1.3. By Region
6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019 - 2032

7.1. Historical Market Value (US$ Bn) Analysis, 2019 - 2024
7.2. Current and Future Market Value (US$ Bn) Projections, 2025 - 2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis , 2019 - 2032

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product, 2019 - 2024
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product, 2025 - 2032
- 8.3.1. Traditional Chinese Medicine (TCM)
  - 8.3.1.1. Autism Spectrum Disorder (ASD)
  - 8.3.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
- 8.3.2. Non-Traditional Chinese Medicine (Non-TCM)
  - 8.3.2.1. Autism Spectrum Disorder (ASD)
  - 8.3.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2019 - 2032, by Disease

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Disease, 2019 - 2024
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Disease, 2025 - 2032
- 9.3.1. Autism Spectrum Disorder (ASD)
- 9.3.2. Attention Deficit Hyperactivity Disorder (ADHD)
9.4. Market Attractiveness Analysis By Disease

10. Global Market Analysis 2019 - 2032, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019 - 2024
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2025 - 2032
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. South Asia
- 10.3.5. East Asia
- 10.3.6. Oceania
- 10.3.7. Middle East and Africa (Middle East and Africa (MEA))
10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019 - 2032

11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Product
- 11.3.3. By Disease
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Product
- 11.4.3. By Disease
11.5. Country Level Analysis & Forecast
- 11.5.1. U.S. Market Analysis
  - 11.5.1.1. Introduction
  - 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.1.2.1. By Product
    - 11.5.1.2.2. By Disease
- 11.5.2. Canada Market Analysis
  - 11.5.2.1. Introduction
  - 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 11.5.2.2.1. By Product
    - 11.5.2.2.2. By Disease
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2019 - 2032

12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Mexico
  - 12.3.1.3. Argentina
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Disease
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By Disease
12.5. Country Level Analysis & Forecast
- 12.5.1. Brazil Market Analysis
  - 12.5.1.1. Introduction
  - 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.1.2.1. By Product
    - 12.5.1.2.2. By Disease
- 12.5.2. Mexico Market Analysis
  - 12.5.2.1. Introduction
  - 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.2.2.1. By Product
    - 12.5.2.2.2. By Disease
- 12.5.3. Argentina Market Analysis
  - 12.5.3.1. Introduction
  - 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 12.5.3.2.1. By Product
    - 12.5.3.2.2. By Disease
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2019 - 2032

13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, By Market Taxonomy, 2025 - 2032
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. France
  - 13.3.1.3. Italy
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. Russia
  - 13.3.1.7. BENELUX
  - 13.3.1.8. Nordic Countries
  - 13.3.1.9. Rest of Europe
- 13.3.2. By Product
- 13.3.3. By Disease
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Disease
13.5. Country Level Analysis & Forecast
- 13.5.1. Germany Market Analysis
  - 13.5.1.1. Introduction
  - 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.1.2.1. By Product
    - 13.5.1.2.2. By Disease
- 13.5.2. France Market Analysis
  - 13.5.2.1. Introduction
  - 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.2.2.1. By Product
    - 13.5.2.2.2. By Disease
- 13.5.3. Italy Market Analysis
  - 13.5.3.1. Introduction
  - 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.3.2.1. By Product
    - 13.5.3.2.2. By Disease
- 13.5.4. U.K. Market Analysis
  - 13.5.4.1. Introduction
  - 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.4.2.1. By Product
    - 13.5.4.2.2. By Disease
- 13.5.5. Spain Market Analysis
  - 13.5.5.1. Introduction
  - 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.5.2.1. By Product
    - 13.5.5.2.2. By Disease
- 13.5.6. Russia Market Analysis
  - 13.5.6.1. Introduction
  - 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.6.2.1. By Product
    - 13.5.6.2.2. By Disease
- 13.5.7. Nordic Countries Market Analysis
  - 13.5.7.1. Introduction
  - 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.7.2.1. By Product
    - 13.5.7.2.2. By Disease
- 13.5.8. BENELUX Market Analysis
  - 13.5.8.1. Introduction
  - 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
    - 13.5.8.2.1. By Product
    - 13.5.8.2.2. By Disease
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2019 - 2032

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 14.3.1. By Country
  - 14.3.1.1. India
  - 14.3.1.2. Thailand
  - 14.3.1.3. Indonesia
  - 14.3.1.4. Malaysia
  - 14.3.1.5. Rest of South Asia
- 14.3.2. By Product
- 14.3.3. By Disease
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Disease
14.5. Country Level Analysis & Forecast
- 14.5.1. India Market Analysis
  - 14.5.1.1. Introduction
  - 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.1.2.1. By Product
    - 14.5.1.2.2. By Disease
- 14.5.2. Thailand Market Analysis
  - 14.5.2.1. Introduction
  - 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.2.2.1. By Product
    - 14.5.2.2.2. By Disease
- 14.5.3. Indonesia Market Analysis
  - 14.5.3.1. Introduction
  - 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.3.2.1. By Product
    - 14.5.3.2.2. By Disease
- 14.5.4. Malaysia Market Analysis
  - 14.5.4.1. Introduction
  - 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.5.4.2.1. By Product
    - 14.5.4.2.2. By Disease
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2019 - 2032

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product
- 15.3.3. By Disease
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Disease
15.5. Country Level Analysis & Forecast
- 15.5.1. China Market Analysis
  - 15.5.1.1. Introduction
  - 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.1.2.1. By Product
    - 15.5.1.2.2. By Disease
- 15.5.2. Japan Market Analysis
  - 15.5.2.1. Introduction
  - 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.2.2.1. By Product
    - 15.5.2.2.2. By Disease
- 15.5.3. South Korea Market Analysis
  - 15.5.3.1. Introduction
  - 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.5.3.2.1. By Product
    - 15.5.3.2.2. By Disease
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2019 - 2032

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Product
- 16.3.3. By Disease
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Disease
16.5. Country Level Analysis & Forecast
- 16.5.1. Australia Market Analysis
  - 16.5.1.1. Introduction
  - 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.1.2.1. By Product
    - 16.5.1.2.2. By Disease
- 16.5.2. New Zealand Market Analysis
  - 16.5.2.1. Introduction
  - 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.5.2.2.1. By Product
    - 16.5.2.2.2. By Disease
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2019 - 2032

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019 - 2024
17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkiye
  - 17.3.1.3. Northern Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Product
- 17.3.3. By Disease
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Disease
17.5. Country Level Analysis & Forecast
- 17.5.1. GCC Countries Market Analysis
  - 17.5.1.1. Introduction
  - 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.1.2.1. By Product
    - 17.5.1.2.2. By Disease
- 17.5.2. Turkiye Market Analysis
  - 17.5.2.1. Introduction
  - 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.2.2.1. By Product
    - 17.5.2.2.2. By Disease
- 17.5.3. Northern Africa Market Analysis
  - 17.5.3.1. Introduction
  - 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.3.2.1. By Product
    - 17.5.3.2.2. By Disease
- 17.5.4. South Africa Market Analysis
  - 17.5.4.1. Introduction
  - 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
    - 17.5.4.2.1. By Product
    - 17.5.4.2.2. By Disease
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard
19.2. Branding and Promotional Strategies
19.3. Key Development Analysis
19.4. Competition Deep Dive
- 19.4.1. Tongrentang
  - 19.4.1.1. Overview
  - 19.4.1.2. Product Portfolio
  - 19.4.1.3. Key Financials
  - 19.4.1.4. Sales Footprint
  - 19.4.1.5. SWOT Analysis
  - 19.4.1.6. Strategy Overview
    - 19.4.1.6.1. Marketing Strategy
    - 19.4.1.6.2. Product Strategy
    - 19.4.1.6.3. Channel Strategy
- 19.4.2. Zhongxin Pharmaceuticals
  - 19.4.2.1. Overview
  - 19.4.2.2. Product Portfolio
  - 19.4.2.3. Key Financials
  - 19.4.2.4. Sales Footprint
  - 19.4.2.5. SWOT Analysis
  - 19.4.2.6. Strategy Overview
    - 19.4.2.6.1. Marketing Strategy
    - 19.4.2.6.2. Product Strategy
    - 19.4.2.6.3. Channel Strategy
- 19.4.3. Tianjin Tasly Group
  - 19.4.3.1. Overview
  - 19.4.3.2. Product Portfolio
  - 19.4.3.3. Key Financials
  - 19.4.3.4. Sales Footprint
  - 19.4.3.5. SWOT Analysis
  - 19.4.3.6. Strategy Overview
    - 19.4.3.6.1. Marketing Strategy
    - 19.4.3.6.2. Product Strategy
    - 19.4.3.6.3. Channel Strategy
- 19.4.4. Yuannan Baiyao
  - 19.4.4.1. Overview
  - 19.4.4.2. Product Portfolio
  - 19.4.4.3. Key Financials
  - 19.4.4.4. Sales Footprint
  - 19.4.4.5. SWOT Analysis
  - 19.4.4.6. Strategy Overview
    - 19.4.4.6.1. Marketing Strategy
    - 19.4.4.6.2. Product Strategy
    - 19.4.4.6.3. Channel Strategy
- 19.4.5. Solstice Medicine Company, Inc.
  - 19.4.5.1. Overview
  - 19.4.5.2. Product Portfolio
  - 19.4.5.3. Key Financials
  - 19.4.5.4. Sales Footprint
  - 19.4.5.5. SWOT Analysis
  - 19.4.5.6. Strategy Overview
    - 19.4.5.6.1. Marketing Strategy
    - 19.4.5.6.2. Product Strategy
    - 19.4.5.6.3. Channel Strategy
- 19.4.6. Shanghai Sundise Traditional Chinese Medicine Co., Ltd
  - 19.4.6.1. Overview
  - 19.4.6.2. Product Portfolio
  - 19.4.6.3. Key Financials
  - 19.4.6.4. Sales Footprint
  - 19.4.6.5. SWOT Analysis
  - 19.4.6.6. Strategy Overview
    - 19.4.6.6.1. Marketing Strategy
    - 19.4.6.6.2. Product Strategy
    - 19.4.6.6.3. Channel Strategy
- 19.4.7. China Chinese Medicine Holding Co., Ltd.
  - 19.4.7.1. Overview
  - 19.4.7.2. Product Portfolio
  - 19.4.7.3. Key Financials
  - 19.4.7.4. Sales Footprint
  - 19.4.7.5. SWOT Analysis
  - 19.4.7.6. Strategy Overview
    - 19.4.7.6.1. Marketing Strategy
    - 19.4.7.6.2. Product Strategy
    - 19.4.7.6.3. Channel Strategy
- 19.4.8. Hunan goldliloo pharmaceutical Co., Ltd
  - 19.4.8.1. Overview
  - 19.4.8.2. Product Portfolio
  - 19.4.8.3. Key Financials
  - 19.4.8.4. Sales Footprint
  - 19.4.8.5. SWOT Analysis
  - 19.4.8.6. Strategy Overview
    - 19.4.8.6.1. Marketing Strategy
    - 19.4.8.6.2. Product Strategy
    - 19.4.8.6.3. Channel Strategy
- 19.4.9. Wanbang Pharma Group Corp.
  - 19.4.9.1. Overview
  - 19.4.9.2. Product Portfolio
  - 19.4.9.3. Key Financials
  - 19.4.9.4. Sales Footprint
  - 19.4.9.5. SWOT Analysis
  - 19.4.9.6. Strategy Overview
    - 19.4.9.6.1. Marketing Strategy
    - 19.4.9.6.2. Product Strategy
    - 19.4.9.6.3. Channel Strategy
- 19.4.10. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
  - 19.4.10.1. Overview
  - 19.4.10.2. Product Portfolio
  - 19.4.10.3. Key Financials
  - 19.4.10.4. Sales Footprint
  - 19.4.10.5. SWOT Analysis
  - 19.4.10.6. Strategy Overview
    - 19.4.10.6.1. Marketing Strategy
    - 19.4.10.6.2. Product Strategy
    - 19.4.10.6.3. Channel Strategy
- 19.4.11. Pfizer Inc.
  - 19.4.11.1. Overview
  - 19.4.11.2. Product Portfolio
  - 19.4.11.3. Key Financials
  - 19.4.11.4. Sales Footprint
  - 19.4.11.5. SWOT Analysis
  - 19.4.11.6. Strategy Overview
    - 19.4.11.6.1. Marketing Strategy
    - 19.4.11.6.2. Product Strategy
    - 19.4.11.6.3. Channel Strategy
- 19.4.12. Eli Lilly and Company
  - 19.4.12.1. Overview
  - 19.4.12.2. Product Portfolio
  - 19.4.12.3. Key Financials
  - 19.4.12.4. Sales Footprint
  - 19.4.12.5. SWOT Analysis
  - 19.4.12.6. Strategy Overview
    - 19.4.12.6.1. Marketing Strategy
    - 19.4.12.6.2. Product Strategy
    - 19.4.12.6.3. Channel Strategy
- 19.4.13. Novartis AG
  - 19.4.13.1. Overview
  - 19.4.13.2. Product Portfolio
  - 19.4.13.3. Key Financials
  - 19.4.13.4. Sales Footprint
  - 19.4.13.5. SWOT Analysis
  - 19.4.13.6. Strategy Overview
    - 19.4.13.6.1. Marketing Strategy
    - 19.4.13.6.2. Product Strategy
    - 19.4.13.6.3. Channel Strategy
- 19.4.14. GlaxoSmithKline PLC
  - 19.4.14.1. Overview
  - 19.4.14.2. Product Portfolio
  - 19.4.14.3. Key Financials
  - 19.4.14.4. Sales Footprint
  - 19.4.14.5. SWOT Analysis
  - 19.4.14.6. Strategy Overview
    - 19.4.14.6.1. Marketing Strategy
    - 19.4.14.6.2. Product Strategy
    - 19.4.14.6.3. Channel Strategy
- 19.4.15. Mallinckrodt Pharmaceuticals
  - 19.4.15.1. Overview
  - 19.4.15.2. Product Portfolio
  - 19.4.15.3. Key Financials
  - 19.4.15.4. Sales Footprint
  - 19.4.15.5. SWOT Analysis
  - 19.4.15.6. Strategy Overview
    - 19.4.15.6.1. Marketing Strategy
    - 19.4.15.6.2. Product Strategy
    - 19.4.15.6.3. Channel Strategy
- 19.4.16. Hisamitsu Pharmaceutical Co., Inc.
  - 19.4.16.1. Overview
  - 19.4.16.2. Product Portfolio
  - 19.4.16.3. Key Financials
  - 19.4.16.4. Sales Footprint
  - 19.4.16.5. SWOT Analysis
  - 19.4.16.6. Strategy Overview
    - 19.4.16.6.1. Marketing Strategy
    - 19.4.16.6.2. Product Strategy
    - 19.4.16.6.3. Channel Strategy

한글목차

목차

제1장 주요 요약

제2장 시장 개요

제3장 주요 시장 동향

제4장 중요 성공 요인

제5장 시장 배경

제6장 COVID-19 위기- 영향 평가

제7장 세계 시장 수요(가치 또는 규모, 10억 달러) 분석, 2019년-2032년

제8장 세계 시장 분석, 제품별, 2019년-2032년

제9장 세계 시장 분석, 질병별, 2019년-2032년

제10장 세계 시장 분석, 지역별, 2019년-2032년

제11장 북미 시장 분석, 2019년-2032년

제12장 라틴아메리카 시장 분석, 2019년-2032년

제13장 유럽 시장 분석, 2019년-2032년

제14장 남아시아 시장 분석, 2019년-2032년

제15장 동아시아 시장 분석, 2019년-2032년

제16장 오세아니아 시장 분석, 2019년-2032년

제17장 중동 및 아프리카 시장 분석, 2019년-2032년

제18장 시장 구조 분석

제19장 경쟁 분석